. Author manuscript; available in PMC: 2019 Apr 1.

Published in final edited form as: J Natl Cancer Inst. 2018 Apr 1;110(4):420–425. doi: 10.1093/jnci/djx218

Table 3.

Treatment received among low-risk patients based on patient preference and baseline sexual function (N=568)

Baseline Sexual Function	Preference to preserve sexual function	AS	RT	RT + ADT	RP	RP + ADT	ADT alone	Other
Normal	Strong (N=120)	39%	21%	3%	36%	0%	2%	0%
Normal	Lower (N=63)	49%	21%	2%	27%	2%	0%	0%
Intermediate	Strong (N=97)	51%	15%	1%	33%	0%	0%	0%
Intermediate	Lower (N=52)	33%	25%	2%	38%	0%	2%	0%
Poor	Strong (N=94)	37%	34%	6%	22%	0%	0%	0%
Poor	Lower (N=142)	49%	22%	4%	22%	0%	1%	2%

Abbreviations: ADT, Androgen Deprivation Therapy; AS, Active Surveillance; NCCN, National Comprehensive Cancer Network; RP, Radical Prostatectomy; RT, Radiotherapy (includes external beam radiotherapy and brachytherapy)